S. Negri et al., IMMUNOREACTIVITY OF APO-B TOWARDS MONOCLONAL-ANTIBODIES THAT INHIBIT THE LDL-RECEPTOR INTERACTION - EFFECTS OF LDL OXIDATION, Atherosclerosis, 101(1), 1993, pp. 37-41
We studied the immunochemical stability of the epitopes for six monocl
onal antibodies to human apolipoprotein B-100 upon Cu2+-mediated (20 m
uM) oxidation of LDL. The antibodies used in this study, some of which
are known to interfere with the interaction of LDL with their cellula
r receptors, recognize epitopes in the amino terminal region (Mb 19),
in the middle part (6B, 2A, 7A, and 9A) and near aa 3500 (Mb 47) of na
tive apo B. All antibodies except one (7A) recognized native and oxidi
zed LDL (OxLDL) equally well; the immunoreactivity of the epitope for
Ab 7A was markedly reduced upon LDL oxidation. Since antibodies 2A, 7A
, 9A, and Mb 47 inhibit the LDL-receptor interaction and OxLDL poorly
interact in vitro with the LDL receptor we conclude that: (1) various
epitopes for monoclonal antibodies against native apo B are spared upo
n LDL oxidation; and (2) the epitopes for antibodies 2A, 9A, and Mb 47
do not define a unique domain of apo B directly involved in the bindi
ng of LDL to their receptor.